PATENT CLAIM ANALYSIS

Application Number: 15760878
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Provided are polypeptides derived from the coronaviruses (CoVs) Spike protein (S) characterized by high affinity and specificity the S receptor and its neutralizing antibodies. Further provided are compositions and vaccines, and vaccine-based therapies targeting CoVs, and SARS and MERS viruses in particular.

Claim (Index 60):
The method according to  claim 59 , wherein:\n (a) said CoV RBM is MERS CoV RBM, and said receptor is CD26/DPP4 or any fragment thereof; or (b) wherein said CoV RBM is SARS CoV RBM, and said receptor is Angiotensin-Converting Enzyme 2 (ACE2) or any fragment thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.35135
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15306617', '10997201', '14375083', '15553466', '14717760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8106159341939672
- 35 USC 102 Novelty (BERT): 0.5537963618767158
- Combined Prediction Score: 0.7849339769622421
- Mean Citation Score: 451.928406
- Max Citation Score: 490.51212
- Similarity Product: 283.12116681093687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test